Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.100
+0.020 (0.96%)
Mar 9, 2026, 3:17 PM EDT - Market open
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $10.36 million as of March 9, 2026. Its market cap has increased by 146.66% in one year.
Market Cap
10.36M
Enterprise Value
3.95M
1-Year Change
146.66%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $10.36M, a decrease of -85.35%. That is a compound annual growth rate of -17.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.20M | -37.31% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectar Biosciences | 11.70M |
| Chemomab Therapeutics | 11.57M |
| CalciMedica | 11.45M |
| Akari Therapeutics, | 11.37M |
| Imunon | 11.02M |
| BiomX | 10.85M |
| Liminatus Pharma | 10.42M |
| Longeveron | 10.32M |